Cancer Immunotherapy: Theory and Application

Cancer Immunotherapy: Theory and Application

Saved in:

Bibliographic Details
Main Authors:	Guobing Chen, Monica Bodogai, Norimasa Tamehiro, Chuanlai Shen, Jun Dou
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2018/7502161
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gastroenterological Cancer and Immunotherapy
by: Xiaoping Wang, et al.
Published: (2018-01-01)

Immunotherapy: An Optimal Control Theory Approach
by: K. Renee Fister, et al.
Published: (2005-07-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)

Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
by: Zhongsong Zhang, et al.
Published: (2025-01-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
by: Anne Mills, et al.
Published: (2023-06-01)

Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era
by: Gavin Hui, et al.
Published: (2019-01-01)

A Cell-Based Evaluation of the Tyrosinase-Mediated Metabolic Activation of Leukoderma-Inducing Phenols, II: The Depletion of <i>Nrf2</i> Augments the Cytotoxic Effect Evoked by Tyrosinase in Melanogenic Cells
by: Tomoko Nishimaki-Mogami, et al.
Published: (2025-01-01)

Novel Cancer Immunotherapies and Antitumor Immunity
by: Lei Zhao, et al.
Published: (2019-01-01)

Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy
by: Xiangrui Zhang, et al.
Published: (2025-01-01)

Integrating AI into Cancer Immunotherapy—A Narrative Review of Current Applications and Future Directions
by: David B. Olawade, et al.
Published: (2025-01-01)

Nano-Oncologic Vaccine for Boosting Cancer Immunotherapy: The Horizons in Cancer Treatment
by: Chao Chen, et al.
Published: (2025-01-01)

Aptamers: A Feasible Technology in Cancer Immunotherapy
by: M. M. Soldevilla, et al.
Published: (2016-01-01)

Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
by: Francesca De Felice, et al.
Published: (2015-01-01)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
by: Kyle K. Payne, et al.
Published: (2012-01-01)

Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy
by: Manal Ali Buabeid, et al.
Published: (2020-01-01)

Natural killer cell engagers for cancer immunotherapy
by: Shahryar Khoshtinat Nikkhoi, et al.
Published: (2025-01-01)

Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
by: Chen Ding, et al.
Published: (2025-02-01)

Research trends on immunotherapy for colorectal cancer: A bibliometric analysis
by: HaoNan Kang, et al.
Published: (2025-02-01)

Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy
by: Shishengnan Song, et al.
Published: (2025-02-01)

Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy
by: Minfeng Yang, et al.
Published: (2025-02-01)

Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies
by: Kira Vordermark, et al.
Published: (2024-12-01)

MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers
by: Yixin Yang, et al.
Published: (2018-01-01)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Dual Roles of IL-27 in Cancer Biology and Immunotherapy
by: Marina Fabbi, et al.
Published: (2017-01-01)

Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
by: Saghar Pahlavanneshan, et al.
Published: (2021-01-01)

Immunotherapy of Brain Cancers: The Past, the Present, and Future Directions
by: Lisheng Ge, et al.
Published: (2010-01-01)

Interferon Lambda: A New Sword in Cancer Immunotherapy
by: Ahmed Lasfar, et al.
Published: (2011-01-01)

Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)

Targeting FMRP: A new window for cancer immunotherapy
by: Yaguang Zhang, et al.
Published: (2023-04-01)

Potential and development of cellular vesicle vaccines in cancer immunotherapy
by: Wenxi Zhao, et al.
Published: (2025-01-01)

ATM in immunobiology: From lymphocyte development to cancer immunotherapy
by: Ji-Hoon Lee
Published: (2025-02-01)

An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
by: Ruyi Liu, et al.
Published: (2025-02-01)

Application of ecological and mathematical theory to cancer: New challenges
by: Yangjin Kim, et al.
Published: (2015-07-01)

The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)

Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
by: Nimeet Desai, et al.
Published: (2025-02-01)

A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01)

Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)
by: Xiguang Chen, et al.
Published: (2025-01-01)

A class of constrained optimal control problems arising in an immunotherapy cancer remission process
by: Yineng Ouyang, et al.
Published: (2024-10-01)

Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
by: Razelle Kurzrock, et al.
Published: (2022-09-01)